“To simulate a state of altered glucocorticoid- and mineralocorticoid-receptor occupation, we administered metyrapone , an 11-beta-hydroxylase inhibitor, that blocks adrenal cortisol synthesis and inhibits the 11-beta-hydroxysteroiddehydrogenase type-1 enzyme in the central nervous system and investigated endocrine changes and the sleep electroencephalogram.”